Cargando…
An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor’s Expression on NK Cells?
The evaluation of chronic pain is challenging because of the lack of specific biomarkers. We identified the Mu opioid receptor-positive (Mu+) B cell percentage of expression, named Mu-Lympho-Marker (MLM), as a candidate marker for chronic pain in fibromyalgia (FM) and osteoarthritis (OA) patients. H...
Autores principales: | Malafoglia, Valentina, Ilari, Sara, Gioia, Chiara, Vitiello, Laura, Tenti, Michael, Iannuccelli, Cristina, Cristiani, Costanza Maria, Garofalo, Cinzia, Passacatini, Lucia Carmela, Viglietto, Giuseppe, Scavalli, Antonio Sili, Tomino, Carlo, Mollace, Vincenzo, Raffaeli, William, Di Franco, Manuela, Muscoli, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046119/ https://www.ncbi.nlm.nih.gov/pubmed/36979910 http://dx.doi.org/10.3390/biomedicines11030931 |
Ejemplares similares
-
Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis
por: Garofalo, Cinzia, et al.
Publicado: (2023) -
Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases †
por: Raffaeli, William, et al.
Publicado: (2020) -
Helper Innate Lymphoid Cells—Unappreciated Players in Melanoma Therapy
por: Garofalo, Cinzia, et al.
Publicado: (2023) -
The Interplay between Chronic Pain, Opioids, and the Immune
System
por: Malafoglia, Valentina, et al.
Publicado: (2021) -
A Review of the Clinical and Therapeutic Implications of Neuropathic Pain
por: Balzani, Eleonora, et al.
Publicado: (2021)